Skip to Content

Logo (Actavis) 855 (Guanfacine Hydrochloride Extended-Release 4 mg)

Pill with imprint Logo (Actavis) 855 is Yellow, Elliptical / Oval and has been identified as Guanfacine Hydrochloride Extended-Release 4 mg. It is supplied by Actavis Pharma, Inc..

Guanfacine is used in the treatment of adhd; high blood pressure; tourette's syndrome and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Guanfacine 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo (Actavis) 855

Guanfacine hydrochloride extended-release 4 mg Logo (Actavis) 855
Guanfacine hydrochloride extended-release 4 mg Logo (Actavis) 855 Front
Guanfacine hydrochloride extended-release 4 mg Logo (Actavis) 855 Back
Guanfacine hydrochloride extended-release 4 mg Logo (Actavis) 855

Guanfacine Hydrochloride Extended-Release

Imprint:
Logo (Actavis) 855
Strength:
4 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, centrally acting
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00228-2855

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide